Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diindolymethane: Anti-proliferation Agent in Thyroid Disease-Non-surgical Protocol

NCT01846364 is registered in ClinicalTrials.gov with The New York Eye & Ear Infirmary as lead sponsor.

NCT NCT01846364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01846364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diindolymethane: Anti-proliferation Agent in Thyroid Disease-Non-surgical Protocol
Lead sponsor
The New York Eye & Ear Infirmary
Phase
Phase 1
Overall status
Terminated
Start date
November 30, 2006
Completion date
September 30, 2011
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative thyroid disease